CDC said to delay vaccine panel meeting after lawsuit challenging its composition
2026-02-19 14:10:21 ET
More on Pfizer, Sanofi, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
- China drug licensing deals surge nearly 10-fold in value since 2021
- NIH director reportedly being tapped as acting CDC director
Read the full article on Seeking Alpha
For further details see:
CDC said to delay vaccine panel meeting after lawsuit challenging its compositionNASDAQ: SNY
SNY Trading
-0.37% G/L:
$43.99 Last:
3,157,504 Volume:
$44.06 Open:



